Sponsored By
An organization or individual has paid for the creation of this work but did not approve or review it.

ADVERTISEMENT

ADVERTISEMENT

Rochester startup given a greenlight by FDA to start selling its medical device

The U.S. Food and Drug Administration has given a greenlight to the young Rochester startup, Pneumeric, to start selling its medical device typically for use in emergency medical situations.

Pneumeric Capnospot
Sasha Gentling, co-founder and executive vice president of Pneumeric, and Dr. John Aho, CEO and chief medical officer, show their Capnospot device attached to a needle angiocatheter Thursday, Sept. 22, 2022, in Rochester. The Capnospot allows the user to detect when carbondioxide flows out the needle during a needle decompression for tension pneumothorax.
Joe Ahlquist / Post Bulletin file photo

ROCHESTER — The U.S. Food and Drug Administration has given a greenlight to a young Rochester startup Pneumeric to start selling its medical device typically for use in emergency medical situations.

“We’ve made extraordinary headway in the past year and some change. Hopefully, we maintain that progress in the next year moving forward, but the outlook is bright,” said CEO and co-founder Dr. John Aho.

Pneumeric, led by Aho and co-founder Sasha Gentling, makes a small tube-like device to help medical teams know if the treatment for pneumothorax, a condition that happens when a patient’s lung collapses and air leaks into the space between the lung and the chest wall, is successful.

To treat pneumothorax, a needle angiocatheter is typically used to poke a hole in the patient’s chest to release the trapped air. The procedure is called a needle thoracostomy. The only way to know if the procedure was successful and doesn’t need to be done again was to listen for the “gushing” sound of the air being released.

Pneumothorax is usually a traumatic emergency situation, which means the treatment is often administered in an ambulance or a helicopter or even on a battlefield. A needle thoracostomy needs to happen quickly in environments that are usually noisy.

ADVERTISEMENT

Pneumeric’s device makes it possible for medical staff to visually determine if a needle thoracostomy worked instead of relying on sound.

Aho created a clear plastic tube or straw with a piece of litmus paper in it that attaches to a needle angiocatheter. He calls it the Pneumeric Capnospot.

“We were judging our success or failure on a procedure based on some auditory signal in an auditory loud environment. … A visual realm is much more obvious,” said Aho. “There's no doubt that the procedure either worked or it did not work.”

Now Pneumeric has been given 510(K) certification from the FDA, the firm can start selling its products to distributors that provide equipment and materials for emergency medical departments, ambulance services and even the military.

Pneumeric Capnospot
Pneumeric's Capnospot, which fits on the end of a needle angiocatheter and allows the user to detect when carbondioxide flows out the needle during a needle decompression for tension pneumothorax. Photographed Thursday, Sept. 22, 2022, in Rochester.
Joe Ahlquist / Post Bulletin file photo

That’s where another award-winning Med City startup comes in. Nanodropper, which makes and sells a precision eye dropper that universally fits on most eye medicine bottles, has agreed to handle fulfillment of Pneumeric at its Rochester distribution center.

“We are just supporting a fellow entrepreneur who also wants to improve the standard of care,” explained Nanodropper’s Communications Director Robbie Spencer.

The leadership of both Pneumeric and Nanodropper have committed to grow their companies in Rochester.

Heard Around Rochester - Jeff Kiger.png

Jeff Kiger writes a daily column, "Heard Around Rochester," in addition to writing articles about local businesses, Mayo Clinic, IBM, Hormel Foods, Crenlo and others. The opinions of my employer do not necessarily reflect my opinions. He has worked in Rochester for the Post Bulletin since 1999. Send tips to jkiger@postbulletin.com or via Twitter to @whereskiger . You can call him at 507-285-7798.
What To Read Next
Get Local

ADVERTISEMENT